STAT July 29, 2024
Ezekiel J. Emanuel, John Connolly

Americans are facing at least two prescription drug crises simultaneously. One is the outrageously high cost of drugs, which runs to more than $500 billion per year. The other relates to extreme drug shortages requiring rationing of lifesaving medications.

Crises can generate opportunities. Mark Cuban, the wildly successful entrepreneur and NBA owner, has committed himself to solving these two problems. Through the creation of the Mark Cuban Cost Plus Drug Company (MCCPDC), Cuban aims to reduce drug prices and also drug shortages.

He has not done this quietly. The pharmaceutical industry, he proclaims, is “the easiest industry I’ve been in to disrupt.”

Though Cuban is well-intentioned, his current approach will fail to significantly dent prices. But by expanding his production...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations
Healthcare leaders urge Congress to recognize pharmacists as providers
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article